From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,593,128 shares, representing 2.11% for $0.89 million under the buyback announced on June 15, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4942 USD | +4.99% | -5.87% | -75.77% |
May. 14 | Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | The Oncology Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-75.77% | 34.59M | |
+22.65% | 87.14B | |
-23.68% | 75.59B | |
+1.76% | 26.78B | |
+3.99% | 17.89B | |
-13.47% | 16.44B | |
+2.68% | 15.68B | |
+69.13% | 13.3B | |
+74.99% | 13.06B | |
+3.11% | 12.54B |
- Stock Market
- Equities
- TOI Stock
- News The Oncology Institute, Inc.
- Tranche Update on The Oncology Institute, Inc.'s Equity Buyback Plan announced on June 15, 2023.